Regular articleCombined administration of barbourin (cas 135402-55-0)–albumin and hirudin–albumin fusion proteins limits fibrin(ogen) deposition on the rabbit balloon-injured aorta

Add time:08/12/2019    Source:sciencedirect.com

IntroductionThere are continuing needs for new antithrombotic agents and procedures. We hypothesized that the slowly cleared recombinant fusion proteins barbourin–albumin (BLAH6) and hirudin–albumin (HLAH6) would be effective in limiting fibrin(ogen) and/or platelet deposition in a rabbit model of arterial injury.

We also recommend Trading Suppliers and Manufacturers of barbourin (cas 135402-55-0). Pls Click Website Link as below: cas 135402-55-0 suppliers

Prev:X-ray and IR studies of N-(tert-butoxycarbonyl)-l-alanine. Comparison with N-(tert-butoxycarbonyl)glycine
Next:Original ResearchEffect of Submaximal and High-Intensity Training on Venous Hemoglobin Concentrations in Thoroughbred Racehorses)